Literature DB >> 2971638

Expression of CR2 (C3d receptor) on the cell membranes of adult T cell leukemia.

C Kai1, N Okada, H Okada.   

Abstract

MT-2 cells, which produce human T-cell lymphotropic virus type I (HTLV-I), are known to have a complement receptor. We have established that the complement receptor is CR2 which binds C3d on immune complexes but not CR1. CR2 was also detected on ATL-3I cells but no complement receptor was detected on ATL-1K cells which lack ATL antigen (ATLA). Since CR2 is not detectable on normal T lymphocytes, the presence of CR2 on some ATL cells might suggest that ATL cells were derived from a particular minor lineage of T cells, or HTLV-I has a capacity to induce CR2, which has been demonstrated to be an a-type growth factor for B lymphocytes and to be a receptor for Epstein-Barr virus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971638      PMCID: PMC5917600          DOI: 10.1111/j.1349-7006.1988.tb00039.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  14 in total

1.  Complement receptors on cell membranes. I. Evidence for two complement receptors.

Authors:  H Okada; K Nishioka
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

2.  Growth control of activated, synchronized murine B cells by the C3d fragment of human complement.

Authors:  F Melchers; A Erdei; T Schulz; M P Dierich
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

3.  Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Authors:  J D Fingeroth; J J Weis; T F Tedder; J L Strominger; P A Biro; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

4.  The effect of divalent cations on the rosette formation via C3 receptors.

Authors:  T Okuda; S Sato; T Tachibana
Journal:  Tohoku J Exp Med       Date:  1984-06       Impact factor: 1.848

5.  Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells.

Authors:  M Seiki; R Eddy; T B Shows; M Yoshida
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

6.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; Y Shiraishi
Journal:  Gan       Date:  1981-12

8.  Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia.

Authors:  H Hoshino; H Esumi; M Miwa; M Shimoyama; K Minato; K Tobinai; M Hirose; S Watanabe; N Inada; K Kinoshita; S Kamihira; M Ichimaru; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.

Authors:  G D Ross; M J Polley; E M Rabellino; H M Grey
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

View more
  3 in total

1.  Selective expression of a protein-tyrosine kinase, p56lyn, in hematopoietic cells and association with production of human T-cell lymphotropic virus type I.

Authors:  Y Yamanashi; S Mori; M Yoshida; T Kishimoto; K Inoue; T Yamamoto; K Toyoshima
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

2.  Epstein-Barr virus in adult T-cell leukemia/lymphoma.

Authors:  M Tokunaga; S Imai; Y Uemura; T Tokudome; T Osato; E Sato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

3.  T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE).

Authors:  E Levy; J Ambrus; L Kahl; H Molina; K Tung; V M Holers
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.